Skip to content
Search

Latest Stories

Delightful Miss Donal Bisht

by ASJAD NAZIR

MODEL and TV anchor turned actress Donal Bisht has shown off impressive versatility with an interesting array of projects.


The small screen beauty has delivered winning performances in popular drama serials, including Ek Deewana Tha, Roop-Mard Ka Naya Swaroop and Dil Toh Happy Hai Ji. With more projects on the way, the unstoppable star will continue to rise.

Eastern Eye caught up with Donal to talk TV, acting and inspirations.

What was it that first connected you to acting?

I always had an interest towards this field from a young age. Even when I was growing up, I always imagined myself playing the heroine’s  part – even when I used to work! Since then, I had a gut feeling that I don’t belong here and have a greater inclination towards acting. And hence, I took a big risk and quit my job to pursue my acting career.

How did you feel being in front of the camera for the first time?

I was never camera conscious as I was in the media and was an anchor of a show on Doordarshan. But my heart always belonged to acting, so that confidence helped me a lot. That’s when I learned that whatever you do in life it never goes to waste and you see the results at some other point of life.

Which of your projects is closest to your heart?

I think Ek Deewana Tha because it gave me a different kind of recognition and was my first show as a lead. I was very pampered as my co-actors and unit never made me realise that I am new into this industry. And fortunately, I got to work with a very good set of people.

How do you approach creating a character?

I try to get into the skin of it. I try to study the nuances and incorporate it while playing the character. Also observing has helped me a lot to improve as an actor.

Do you have a dream role you would love to play?

I loved Alia Bhatt in Raazi and her character in the movie. I would love to play something like that.

What do you enjoy watching as an audience member?

I enjoy watching web shows. Also, I have watched around 40-50 films in this lockdown and all were award-winning movies. And mainly, good content is imperative. If it’s films, web or TV, I’ll watch it if the content is good.

Who is your acting hero?

I’ve adored Leonardo Di- Caprio since his path-breaking performance in Catch Me If You Can and love Brad Pitt too, because they have the looks and great acting skills. In Bollywood, I love Ranbir Kapoor and think nobody can beat him.

Who would you love to work with?

I want to work with all the great actors, because it is more of a learning process when you work with the best, like the three Khans of Bollywood. I also aspire to work with Amitabhji (Bachchan), and among the women, Alia Bhatt and Priyanka Chopra. Also, it is my biggest dream to work with Mr Sanjay Leela Bhansali, as he has made quite a few masterpieces.

If you could master something new what would that be?

I am a creative person, so won’t limit myself with just one thing. But I would love to learn and master dancing as I never learnt it professionally. Apart from that, painting is also one thing I would want to master.

What inspires you?

People who achieve it big in their lives! I think that is the biggest motivation for me. No matter whichever field they belong to, but it gives me the push to do better in life and encourages me that if they can do it, then why not me? I think we have many examples in our surroundings and everyone teaches us something or the other.

More For You

Shefali Jariwala

Glutathione and anti ageing drugs under spotlight after Shefali Jariwala death

Instagram/shefalijariwala

Did anti-ageing pills, beauty supplements and glutathione trigger Shefali Jariwala’s death?

Quick highlights:

  • Shefali Jariwala died at 42 in Mumbai after reportedly collapsing post-fast; cause of death suspected to be cardiac arrest or blood pressure drop.
  • Police found anti-ageing pills, vitamin supplements, and glutathione injections at her residence.
  • Doctors stress the risks of unsupervised use of hormone-based and anti-ageing treatments.
  • Final post-mortem report expected in two days; no foul play suspected, case treated as accidental death.

The untimely death of actor-model Shefali Jariwala has sparked renewed concern over the unregulated use of anti-ageing treatments and self-medication. The 42-year-old, best known for her appearance in Kaanta Laga, was declared dead on arrival at a Mumbai hospital on Friday night. Initial investigations suggest she may have suffered a cardiac arrest following a steep drop in blood pressure, possibly linked to taking supplements on an empty stomach.

Keep ReadingShow less
Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less